Serum cytokeratin-18 fragment level: A noninvasive biomarker for not only nonalcoholic steatohepatitis, but also alcoholic steatohepatitis

Hepatology

Volumn 51, Issue 5, 2010, Pages 1865-1866

  Li, Xiaohua ^a   Zhang, Ying ^a   Wu, Kaichun ^a   Fan, Daiming ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CYTOKERATIN 18;

ALCOHOLIC FATTY LIVER; BLOOD LEVEL; CONTROLLED STUDY; CYTOSKELETON; DIAGNOSTIC VALUE; EPITHELIUM CELL; GENOTYPE; HUMAN; LETTER; LIVER CELL CARCINOMA; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL;

BIOLOGICAL MARKERS; FATTY LIVER; FATTY LIVER, ALCOHOLIC; HUMANS; KERATIN-18; PEPTIDE FRAGMENTS;

EID: 77951455040     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.23433     Document Type: Letter

References (6)

1. Feldstein AE, Wieckowska A, Lopez AR, Liu YC, Zein NN, McCullough AJ. Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study. Hepatology 2009;50:1072-1078.
2. Omary M B, Ku NO, Toivola DM. Keratins: guardians of the liver. Hepatology 2002;35:251-257.
3. Barak V, Goike H, Panaretakis KW, Einarsson R. Clinical utility of cytokeratins as tumor markers. Clin Biochem 2004;37:529-540. (Pubitemid 38845016)
4. Kashiwabara K, Nakamura H, Kiguchi T, Matsuoka T. Correlation between serum cytokeratin 19 fragment and tissue polypeptide antigen in patients with non-malignant diseases. Clin Chim Acta 1998;273:35-42. (Pubitemid 29044053)
5. Molina R, Agustí C, Filella X, Jo J, Joseph J, Gimenez N, et al. Study of a new tumor marker, CYFRA 21-1, in malignant and non-malignant diseases. Tumour Biol 1994;15:318-325. (Pubitemid 24369415)
6. Quintela AG, Garcia J, Campos J, Perez LF, Alende MR, Otero E, et al. Serum cytokeratins in alcoholic liver disease: contrasting levels of cytokeratin-18 and cytokeratin-19. Alcohol 2006;38:45-49. (Pubitemid 43833397)